Goldman Sachs Knock-Out PGR/ DE000GG8NNN7 /
2024-08-30 9:41:48 PM | Chg.+0.19 | Bid10:00:31 PM | Ask10:00:31 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
4.52EUR | +4.39% | - Bid Size: - |
- Ask Size: - |
Progressive Corporat... | 202.5985 USD | 2078-12-31 | Call |
GlobeNewswire
08-19
Emergent BioSolutions Responds to Mpox Public Health Emergency as Cases Surge in Africa
GlobeNewswire
08-19
Fulcrum Therapeutics Strengthens Leadership Team with the Appointments of Isabel Kalofonos as Chief ...
GlobeNewswire
08-15
Abata Therapeutics Announces Strategic Investment from Bristol Myers Squibb Supporting Advancement o...
GlobeNewswire
08-14
Atsena Therapeutics Receives Rare Pediatric Disease Designation from the U.S. FDA for ATSN-201 Gene ...
GlobeNewswire
08-14
Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price Rule
GlobeNewswire
08-13
Eyenovia to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
GlobeNewswire
08-12
Eyenovia Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Newsfile Corp
08-12
The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors
GlobeNewswire
08-08
Opthea to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference, August 15,...
GlobeNewswire
08-07
Eyenovia and Formosa Pharmaceuticals Initiate Co-Development of Clobetasol Propionate Ophthalmic Sus...
GlobeNewswire
08-07
AGS Unveils its Latest Table Innovation Bonus Spin Xtreme for Poker Rooms and an Exciting New Lineup...
GlobeNewswire
08-07
Team, Inc. Announces Timing of Second Quarter Earnings Release and Conference Call
GlobeNewswire
08-06
TG Therapeutics Reports Second Quarter 2024 Financial Results and Raises BRIUMVI® (ublituximab-xiiy)...
GlobeNewswire
08-06
Levicept Announces Positive Results of Phase II Trial of novel Neurotrophin-3 Inhibitor, LEVI-04, fo...
GlobeNewswire
08-05
NeOnc Technologies Begins Enrollment for Phase 2 Clinical Trial of NEO100-02™ for Patients Afflicted...